Improvement of 'dynamic analgesia' does not decrease atelectasis after thoracotomy
N Boisseau, O Rabary, B Padovani, P Staccini, J Mouroux, D Grimaud, M Raucoules-Aimé, N Boisseau, O Rabary, B Padovani, P Staccini, J Mouroux, D Grimaud, M Raucoules-Aimé
Abstract
There is still controversy concerning the beneficial aspects of 'dynamic analgesia' (i.e. pain while coughing or moving) on the reduction of postoperative atelectasis. In this study, we tested the hypothesis that thoracic epidural analgesia (TEA) prevents these abnormalities as opposed to multimodal analgesia with i.v. patient controlled analgesia (i.v. PCA) after thoracotomy. Fifty-four patients undergoing thoracotomy (lung cancer) were randomly assigned to one of the two groups. Clinical respiratory characteristics, arterial blood gas, and pulmonary function tests (forced vital capacity and forced expiratory volume in 1 s) were obtained before surgery and on the next 3 postoperative days. Atelectasis was compared between the two groups by performing computed tomography (CT) scan of the chest at day 3. Postoperative respiratory function and arterial blood gas values were reduced compared with preoperative values (mean (SD) FEV1 day 0: 1.1 (0.3) litre; 1.3 (0.4) litre) but there was no significant difference between groups at any time. PCA and TEA provided a good level of analgesia at rest (VAS day 0: 21 (15/100); 8 (9/100)), but TEA was more effective for analgesia during mobilization (VAS day 0: 52 (3/100); 25 (17/100)). CT scans revealed comparable amounts of atelectasis (expressed as a percentage of total lung volume) in the TEA (7.1 (2.8)%) and in the i.v. PCA group (6.71 (3.2)%). There was no statistical difference in the number of patients presenting with at least one atelectasis of various types (lamellar, plate, segmental, lobar).
Source: PubMed
Prochains essais cliniques
-
University of TennesseeWoodcock Institute for the Advancement of Neurocognitive Research and Applied...Pas encore de recrutementMotricité | En bonne santé | Fonction exécutive
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLCPas encore de recrutementCarcinome épidermoïde anal
-
Universita di VeronaAzienda Ospedaliera Universitaria Integrata VeronaPas encore de recrutementLa polyarthrite rhumatoïde | Maladie articulaire dégénérative du genouItalie
-
University of Wisconsin, MadisonAlkermes, Inc.Pas encore de recrutement
-
Virginia Commonwealth UniversityPas encore de recrutement
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH); Icahn School of Medicine at Mount...Pas encore de recrutementKétamine | IRMf | Dépression - Trouble dépressif majeur | SMTr | Dépression résistante au traitement (TRD)États-Unis
-
Weill Medical College of Cornell UniversityBD2 LLCPas encore de recrutementIRMf | Trouble bipolaire (TB) | SMTr | Dépression bipolaire 1États-Unis
-
Xentria, Inc.Pas encore de recrutement
-
Yale UniversityNational Institute of Mental Health (NIMH)Pas encore de recrutement
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecrutementPhéochromocytome | Phéochromocytome/Paragangliome | Phéochromocytome métastatique | Phéochromocytome malin | Phéochromocytome et paragangliome (PPGL)Royaume-Uni
-
Carl Zeiss Meditec-Dublin CoCeRecrutementMembrane épirétinienne | Maladie de la rétine | Dégénérescence maculaire liée à l'âge sec | Anomalie vitréorétinienne | Macular Abnormalities | Intraretinal Hyporeflective Space | Subretinal Hyporeflective Space | IS/OS (Ellipsoid Zone) Disruption | Retinal Pigment Epithelium (RPE) Elevation | Retinal...États-Unis
-
Celest Therapeutics (Shanghai) Co., Ltd.The First Affiliated Hospital of Anhui Medical UniversityRecrutementCLDN18.2 Tumeurs solides positivesChine